IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $282,077 | -16.1% | 17,853 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $336,172 | +425.7% | 17,853 | +7.2% | 0.00% | – |
Q1 2023 | $63,948 | -87.8% | 16,653 | -84.3% | 0.00% | -100.0% |
Q4 2022 | $525,279 | +13.2% | 105,903 | +9.1% | 0.00% | 0.0% |
Q3 2022 | $464,000 | +5.2% | 97,035 | -1.0% | 0.00% | 0.0% |
Q2 2022 | $441,000 | +14.5% | 98,037 | +21.3% | 0.00% | 0.0% |
Q1 2022 | $385,000 | -33.0% | 80,816 | +4.4% | 0.00% | 0.0% |
Q4 2021 | $575,000 | +47.8% | 77,446 | +13.0% | 0.00% | 0.0% |
Q3 2021 | $389,000 | -7.4% | 68,530 | +7.4% | 0.00% | 0.0% |
Q2 2021 | $420,000 | -19.7% | 63,796 | -21.3% | 0.00% | 0.0% |
Q4 2020 | $523,000 | – | 81,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |